Primary Amyloidosis — Trials

Primary Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

106 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04895917	Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis(DarPAL)	terminated	Phase 2	27	Fondazione IRCCS Policlinico San Matteo di PaviaOTHER	1	Feb 20, 2025	clinicaltrials
NCT01728259	First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD	terminated	Phase 1	18	Barbara Ann Karmanos Cancer InstituteOTHER	2	May 9, 2023